Sangamo Therapeutics (NASDAQ:SGMO) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a research note issued to investors on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. SGMO has been the topic of a number of other research reports. Royal Bank of Canada reissued a sector perform rating and […]

Related Keywords

Canada ,United States , ,Sangamo Therapeutics Inc ,Wells Fargo Company ,Hsbc Holdings ,Penserra Capital Management ,Royal Bank ,Lazard Asset Management ,Alphacrest Capital Management ,Biogen Inc ,Sangamo Therapeutics ,Free Report ,Therapeutics Trading Down ,Get Free Report ,Capital Management ,Asset Management ,Crest Capital Management ,Engineers Gate Manager ,Sangamo Therapeutics Daily ,Nasdaq Sgmo ,Sgmo ,Medical ,80067710 ,Initiated Coverage ,Stocknews Com ,